Datasets:

Suchinthana
/

support2-1

Dataset card Data Studio Files Files and versions Community

Split (1)

train · 9.11k rows

ID int64 1 9.11k	age float64 18 102	death int64 0 1	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	d.time int64 3 2.03k	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07
4,501	68.27399	0	male	0	15	977	ARF/MOSF w/Sepsis	ARF/MOSF	1	3	$11-$25k	0	51,694	31,447.4531	29,663	26.666656	white	18.597656	35	0.862915	0.814941	1	0	no	0.8	0.7	no dnr	15	75	null	100	21	36.19531	null	null	0.5	1.299805	141	null	91	9	4,575	null	0	no(M2 and SIP pres)	0
4,502	68.89294	1	male	1	22	22	COPD	COPD/CHF/Cirrhosis	3	4	under $11k	0	43,100	27,005.6719	26,722	17.666656	black	23.199219	22	0.805908	0.68689	1	0	no	0.6	0.5	dnr after sadm	18	57	11.398438	150	10	39.89844	102	null	2.099609	0.799927	136	7.349609	101	18	2,080	null	1	<2 mo. follow-up	1
4,503	66.92694	1	female	0	6	104	Lung Cancer	Cancer	2	14	null	0	8,787	4,992.8555	3,342	11	white	18	12	0.68396	0.389954	1	0	metastatic	0.6	0.2	no dnr	6	69	1.099854	106	26	35.89844	472	2.5	1.5	1.199951	127	7.399414	196	10	1,680	3	2	null	2
4,504	79.23297	1	female	0	14	865	COPD	COPD/CHF/Cirrhosis	2	7	under $11k	0	150,446	95,675.0625	81,663	18	white	26.199219	22	0.562988	0.366943	35	0	no	0.5	0.4	no dnr	14	103	14.699219	128	42	36.69531	364	1.899902	6.399414	2.199707	147	7.389648	113	43	1,670	null	0	SIP>=30	0
4,505	44.82999	1	female	1	4	4	Cirrhosis	COPD/CHF/Cirrhosis	3	14	under $11k	100	4,454	null	null	12	white	46.296875	96	0.004999	0	1	0	no	null	null	dnr after sadm	2	103	15	114	24	33.79688	256.5	2.099609	9.798828	1	141	7.40918	113	14	1,575	null	null	<2 mo. follow-up	3.859863
4,506	66.71295	1	male	1	6	6	ARF/MOSF w/Sepsis	ARF/MOSF	2	14	under $11k	0	130,396	84,253.5625	71,807	45	white	38	69	0.375977	0.257996	23	0	no	0.2	0.1	dnr after sadm	2	100	14.699219	118	24	36.69531	276.625	null	null	1.099854	135	7.469727	107	18	1,445	null	0	<2 mo. follow-up	0
4,507	70.92694	1	female	1	9	9	MOSF w/Malig	ARF/MOSF	1	16	$25-$50k	0	113,333	69,972.8125	73,117	54	white	46	86	0.039993	0.011999	32	0	yes	0.3	0.3	no dnr	9	74	4.099609	74	10	36.59375	290.4375	null	null	0.899902	135	7.40918	210	22	2,090	null	0	<2 mo. follow-up	0
4,508	64.07397	1	male	1	15	15	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	9	78,530	48,207.4375	43,088	37.333313	black	24.199219	58	0.756958	0.679932	3	1	no	null	null	dnr after sadm	15	77	16.097656	100	30	35.09375	90	null	null	1.5	146	7.229492	430	27	null	null	null	<2 mo. follow-up	2.287598
4,509	63.948	0	male	0	12	973	CHF	COPD/CHF/Cirrhosis	1	null	$11-$25k	0	22,745	13,961.0625	13,437	28.5	black	26.898438	36	0.774902	0.641968	1	0	no	0.6	0.6	no dnr	12	66	32.695313	64	29	35.79688	134	2	null	1.599854	132	7.399414	110	21	380	0	0	no(M2 and SIP pres)	0
4,510	66.47498	0	female	0	7	972	CHF	COPD/CHF/Cirrhosis	3	13	$11-$25k	0	5,886	4,096.3672	3,634	10.5	black	20.898438	27	0.846924	0.748901	1	1	no	null	null	no dnr	7	65	16.699219	104	40	36.5	200	2.399902	22.5	1.199951	139	7.459961	199	38	4,450	1	null	no(M2 and SIP pres)	1.166748
4,511	54.92398	1	male	1	6	6	Coma	Coma	2	null	null	100	25,869	19,248.6094	14,186	16	null	20.699219	38	0.32196	0.250977	6	0	no	null	null	dnr after sadm	1	67	4.5	100	22	36	null	null	0.399963	1	139	null	98	19	1,500	null	null	<2 mo. follow-up	2.609375
4,512	57.91397	1	female	0	5	17	Lung Cancer	Cancer	1	12	>$50k	0	7,104	null	null	8	white	22	25	0.616943	0.302979	1	0	metastatic	0.5	0.2	no dnr	5	71	13.5	73	25	36.69531	155	null	0.699951	7.099609	148	7.40918	200	57	1,960	5	4	<2 mo. follow-up	4
4,513	30.84698	1	female	0	66	896	ARF/MOSF w/Sepsis	ARF/MOSF	2	11	null	100	95,845	64,135.25	69,807	16.75	black	22.097656	20	0.671997	0.575928	1	0	no	0.9	0.95	no dnr	66	65	14.798828	50	12	36.89844	152.5	2.099609	0.799927	0.799927	136	7.459961	108	18	780	null	null	null	3.235352
4,514	36.92499	1	female	1	28	28	ARF/MOSF w/Sepsis	ARF/MOSF	0	14	$11-$25k	0	151,066	95,726.5	83,119	33.25	white	30	45	0.815918	0.754883	1	0	no	0.6	0.6	dnr after sadm	14	129	11.398438	56	45	39.39844	284	null	null	0.899902	144	7.459961	243	12	2,110	null	0	<2 mo. follow-up	0
4,515	44.32898	1	male	0	5	864	CHF	COPD/CHF/Cirrhosis	3	8	$25-$50k	0	null	null	null	11	white	21.597656	22	0.897949	0.829956	1	1	no	0.8	0.7	null	null	83	null	70	12	36.29688	null	null	null	null	140	null	282	null	3,800	0	null	no(M2 and SIP pres)	0.494751
4,516	47.37299	1	female	1	24	24	Cirrhosis	COPD/CHF/Cirrhosis	3	16	null	0	101,234	67,325.0625	57,193	40.333313	black	55.59375	82	0.054993	0.006	1	0	no	0.5	0.5	dnr after sadm	20	97	28.796875	106	46	38	151	2.399902	1.5	1.299805	136	7.449219	87	17	2,950	null	1	<2 mo. follow-up	1
4,517	67.53699	1	male	0	8	54	CHF	COPD/CHF/Cirrhosis	2	null	under $11k	0	16,884	10,548.1094	9,162	17	black	17.597656	20	0.868896	0.782959	2	0	no	0.5	0.5	no dnr	8	100	6	84	24	36.29688	176.1875	null	0.699951	0.699951	140	7.339844	115	18	3,025	null	4	<2 mo. follow-up	4
4,518	59.76199	1	male	0	6	136	Lung Cancer	Cancer	1	6	$11-$25k	0	13,286	6,966.7109	5,383	15	black	15.298828	22	0.751953	0.493958	1	0	metastatic	0.5	0.25	no dnr	6	77	7.099609	80	20	36.09375	null	3.699707	0.5	0.799927	139	null	157	12	2,650	2	2	SIP>=30	2
4,519	67.55096	1	male	1	3	3	MOSF w/Malig	ARF/MOSF	1	null	null	37	49,159	30,353.2031	25,562	31	null	59.195313	98	0	0	12	0	yes	null	null	no dnr	3	53	8.898438	110	23	36	197.9375	null	null	3.099609	129	7.339844	108	103	380	null	null	<2 mo. follow-up	1.974365
4,520	77.659	1	male	0	61	162	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	9	219,246	146,584.75	144,700	40.75	white	28	44	0.612915	0.506958	3	0	no	null	null	no dnr	61	115	9.5	70	23	36.09375	null	3.699707	0.799927	1.199951	142	null	112	7	4,600	null	0	adl>=4 (>=5 if sur)	0
4,521	72.42395	1	male	0	21	656	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	0	30,845	20,463.3125	20,964	19.666656	white	24	42	0.781982	0.710938	1	0	no	0.85	0.75	no dnr	21	65	20.398438	136	12	39.59375	208	1.899902	0.399963	0.899902	135	7.40918	72	7	2,010	null	null	null	2.82666
4,522	37.71698	1	female	1	27	27	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	123,504	83,198.125	66,476	42.25	white	35	64	0.733887	0.651978	1	0	no	0.25	0.25	dnr after sadm	10	55	12.199219	74	38	35.5	290	null	null	5.799805	139	7.40918	218	120	110	null	6	<2 mo. follow-up	6
4,523	73.22699	1	female	0	113	173	Coma	Coma	0	2	null	55	173,742	123,581.25	124,106	28	white	22.5	18	0.396973	0.322998	1	0	no	null	null	dnr after sadm	38	121	8.298828	124	32	36.09375	162.5	null	1.5	0.699951	145	7.519531	179	35	1,755	null	1	adl>=4 (>=5 if sur)	1
4,524	56.05698	1	female	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	4	15	$11-$25k	61	44,639	29,698.5469	29,694	12	black	77.890625	94	0	0	22	1	no	0.1	0.1	dnr after sadm	2	0	15.798828	0	0	35.5	232.5	null	null	2	153	7.449219	378	26	5,635	null	3	<2 mo. follow-up	3
4,525	63.84698	1	male	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	2	20	>$50k	100	39,993	25,133.3281	23,895	3	white	31.796875	48	0.132996	0.060997	5	1	no	null	null	dnr after sadm	2	73	14.699219	130	32	36.19531	300	2.599609	1.099854	2	141	7.439453	150	28	443	null	null	<2 mo. follow-up	3.532715
4,526	68.73895	0	male	0	12	965	COPD	COPD/CHF/Cirrhosis	1	null	null	0	11,075	7,144.2578	8,268	11	other	17.898438	15	0.869995	0.783936	1	0	no	0.9	0.8	dnr after sadm	10	156	14.599609	124	32	38.19531	208.5625	null	null	0.899902	146	7.439453	297	47	2,010	null	null	null	2.753418
4,527	67.35095	1	female	0	7	69	Lung Cancer	Cancer	1	11	$25-$50k	0	12,901	7,968.5469	7,785	3.5	white	20.597656	19	0.623901	0.310974	1	0	metastatic	0.9	0.75	no dnr	7	69	14.398438	114	36	36.29688	87.75	null	null	1	138	7.429688	160	23	3,050	4	3	null	3
4,528	43.047	1	female	1	5	5	MOSF w/Malig	ARF/MOSF	1	16	$25-$50k	0	20,626	15,471.5938	11,961	48	white	29.597656	28	0.527954	0.411987	1	0	metastatic	0.2	0.1	dnr after sadm	3	59	17	116	16	38.79688	145.4375	2.899902	0.699951	1.099854	137	7.479492	128	19	1,250	null	null	<2 mo. follow-up	2.361328
4,529	50.71597	1	male	0	5	297	Colon Cancer	Cancer	1	14	null	0	5,168	3,181.8672	3,450	13	black	7.799805	29	0.921997	0.816895	1	0	metastatic	null	null	no dnr	5	69	16.097656	70	14	38.19531	212.5	1.699951	1.699951	1.699951	142	7.419922	199	53	3,865	1	1	no(M2 and SIP pres)	1
4,530	58.448	1	female	1	9	9	MOSF w/Malig	ARF/MOSF	1	16	>$50k	0	53,336	33,709.875	27,935	43.5	white	33.296875	47	0.449951	0.329956	2	0	yes	0.3	0.2	dnr after sadm	9	82	10	72	20	37	null	4.199219	0.399963	0.899902	141	null	96	12	null	4	5	<2 mo. follow-up	5
4,531	36.62097	1	female	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$25-$50k	37	40,649	26,247.6094	23,098	42	white	42.5	81	0.390991	0.271973	1	0	no	0.5	0.5	dnr after sadm	7	69	19.898438	66	20	37.39844	148.96875	2.699707	null	3.899902	130	7.5	237	62	2,970	null	0	<2 mo. follow-up	0
4,532	41.92697	1	female	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$25-$50k	44	206,256	138,603.875	142,798	47.5	white	22.597656	41	0.721924	0.635986	22	0	no	0.75	0.7	dnr after sadm	7	113	7.699219	74	22	33.79688	230.59375	1.899902	0.699951	1.099854	135	7.329102	290	15	2,240	null	0	<2 mo. follow-up	0
4,533	24.101	0	female	0	10	958	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	null	0	10,079	6,416.2148	6,694	12.5	white	20.699219	36	0.927979	0.901978	1	0	no	1	0.75	no dnr	10	49	13	60	6	36.79688	265	2.399902	1.599854	2	150	7.369141	100	66	1,490	2	3	adl>=4 (>=5 if sur)	3
4,534	76.97198	1	male	0	8	608	CHF	COPD/CHF/Cirrhosis	4	null	$11-$25k	0	17,070	10,639.7812	10,958	11.5	white	20.796875	34	0.813965	0.697998	1	1	no	0.8	0.75	no dnr	8	73	8.5	46	16	35.79688	152.375	null	1.099854	1.799805	144	7.429688	88	29	1,000	0	0	no(M2 and SIP pres)	0
4,535	68.62994	0	male	0	69	960	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	37	134,910	null	null	22.75	black	18.597656	24	0.720947	0.634888	8	0	no	0.5	0.3	no dnr	69	39	1	144	28	38.89844	160	2.299805	2.199707	5	143	7.219727	70	68	975	null	0	adl>=4 (>=5 if sur)	0
4,536	50.23099	1	male	0	44	312	MOSF w/Malig	ARF/MOSF	1	12	null	0	151,085	98,833.75	96,276	27.25	white	39.695313	74	0.221985	0.123993	1	0	metastatic	null	null	dnr after sadm	10	52	9.398438	64	16	36.5	null	3.099609	0.599976	0.799927	138	null	294	9	5,525	null	4	adl>=4 (>=5 if sur)	4
4,537	52.91199	1	male	1	9	9	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	null	0	101,406	63,986.6562	56,224	34	white	24.699219	34	0.718994	0.632935	30	0	yes	0.5	0.2	dnr after sadm	3	151	9.798828	134	30	35.29688	174	null	0.399963	4	132	7.369141	129	50	670	null	3	<2 mo. follow-up	3
4,538	62.86398	0	male	0	5	957	CHF	COPD/CHF/Cirrhosis	4	16	$25-$50k	0	null	null	null	7	white	13	13	0.922974	0.869995	1	1	no	0.9	0.8	null	null	0	7.199219	0	10	36.09375	115	2.399902	17.699219	1.099854	139	7.399414	51	23	195	1	0	no(M2 and SIP pres)	0
4,539	38.78198	1	male	0	8	63	CHF	COPD/CHF/Cirrhosis	1	16	under $11k	0	8,195	5,477.7969	5,594	8.5	white	22.796875	17	0.899902	0.832886	1	0	no	0.8	0.7	no dnr	8	153	18.898438	160	40	36.19531	156	null	0.699951	0.5	131	7.429688	78	6	1,945	0	null	null	0.494751
4,540	42.83398	0	female	0	68	956	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	0	293,248	206,553.625	219,449	42	black	27.398438	44	0.767944	0.69397	28	0	no	0.75	0.65	no dnr	68	53	17.5	120	14	38.39844	147.125	2.599609	1	1	135	7.489258	124	16	2,320	null	0	adl>=4 (>=5 if sur)	0
4,541	63.44397	1	female	1	4	4	Coma	Coma	1	null	null	100	20,151	13,220.0391	11,825	38	white	30.898438	72	0.070999	0.039993	1	0	no	null	null	dnr after sadm	2	70	5.599609	62	20	36.39844	null	null	0.899902	0.899902	138	null	79	11	null	null	null	<2 mo. follow-up	2.631348
4,542	71.10699	1	female	0	14	79	COPD	COPD/CHF/Cirrhosis	2	10	under $11k	0	11,445	7,709.0078	8,895	7.333332	white	21.097656	26	0.778931	0.647949	1	0	yes	0.6	0.5	dnr after sadm	2	55	39.59375	104	10	36.59375	164	null	1.599854	1.899902	133	7.339844	253	122	618	null	0	no(M2 and SIP pres)	0
4,543	53.73898	1	female	1	86	86	MOSF w/Malig	ARF/MOSF	2	16	>$50k	0	264,539	180,809.375	156,199	36.75	white	25.296875	64	0.618896	0.514893	1	0	metastatic	0.4	0.2	dnr after sadm	4	119	9.398438	44	42	39.79688	363.3125	null	null	1.099854	143	7.519531	133	17	2,230	null	0	adl>=4 (>=5 if sur)	0
4,544	19.14899	0	male	0	16	953	ARF/MOSF w/Sepsis	ARF/MOSF	0	11	$11-$25k	0	43,894	29,063.0938	25,630	13.333328	black	26.199219	32	0.878906	0.836914	5	0	no	0.9	0.9	no dnr	16	79	7.599609	92	26	39	null	3	0.599976	2.099609	139	null	99	21	2,425	0	5	no(M2 and SIP pres)	5
4,545	68.31995	1	male	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	$11-$25k	0	56,203	35,560.4375	29,180	34	white	46.59375	102	0.166992	0.084	6	0	no	null	null	dnr after sadm	3	99	2.5	100	24	36.69531	null	3.799805	0.599976	1.299805	138	null	339	23	null	null	6	<2 mo. follow-up	6
4,546	72.99097	1	male	1	14	14	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	0	62,598	41,066.875	35,585	19	black	30.796875	49	0.575928	0.465942	1	0	yes	0.7	0.6	dnr after sadm	12	75	5.799805	56	16	36.59375	null	4.099609	0.399963	1.299805	138	null	249	48	2,225	null	1	<2 mo. follow-up	1
4,547	72.90295	1	male	0	8	36	Lung Cancer	Cancer	2	12	null	0	5,657	3,751.4981	3,824	6.5	white	38.398438	52	0.120987	0.004999	1	1	metastatic	1	0.95	no dnr	8	107	14.298828	124	10	35.69531	127.5	3.299805	0.5	2.5	131	7.519531	103	128	3,145	7	6	<2 mo. follow-up	6
4,548	19.96199	0	female	0	28	951	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$25-$50k	0	105,433	71,099.1875	59,291	36.25	black	31.5	53	0.848999	0.796997	1	0	no	0.75	0.7	no dnr	28	75	10.898438	72	36	37.89844	228	3.899902	null	1.399902	134	7.289062	105	21	6,710	null	0	no(M2 and SIP pres)	0
4,549	63.74298	0	female	0	15	950	CHF	COPD/CHF/Cirrhosis	1	15	$25-$50k	0	50,256	30,249.4531	25,637	18.333328	white	14.898438	27	0.908936	0.845947	1	0	no	0.9	0.75	no dnr	15	119	16.597656	66	34	35.29688	376	3.199707	1	0.799927	139	7.449219	199	27	3,485	0	2	no(M2 and SIP pres)	2
4,550	59.48798	1	male	0	9	149	Colon Cancer	Cancer	1	12	$11-$25k	0	11,417	7,147.6914	7,076	8	white	16.597656	20	0.832886	0.634888	1	0	metastatic	null	null	no dnr	9	70	7.699219	64	18	36.39844	null	3.199707	0.5	1	139	null	113	9	4,000	0	0	SIP>=30	0
4,551	31.797	0	male	0	51	950	ARF/MOSF w/Sepsis	ARF/MOSF	1	11	$11-$25k	0	113,949	73,953.375	72,932	31.75	white	26.796875	53	0.86792	0.821899	1	1	no	0.6	0.6	dnr after sadm	10	109	3.399902	116	28	36.5	320	3	0.399963	0.899902	129	7.479492	76	13	3,820	null	1	no(M2 and SIP pres)	1
4,552	65.45898	1	female	0	9	41	CHF	COPD/CHF/Cirrhosis	2	6	null	0	12,912	9,768.9141	6,986	15	white	20.898438	31	0.850952	0.754883	1	0	no	0.99	0.95	no dnr	9	60	15.599609	140	36	35	null	2.199707	18.097656	6.299805	126	null	111	51	80	0	2	<2 mo. follow-up	2
4,553	74.672	1	male	1	3	3	MOSF w/Malig	ARF/MOSF	1	8	null	0	48,434	28,172.8281	31,747	44	white	89.6875	96	0	0	16	0	yes	null	null	dnr after sadm	3	61	21.296875	104	35	38.5	225	2.299805	28.5	6.899414	131	7.349609	142	110	1,320	null	null	<2 mo. follow-up	1.112793
4,554	58.40698	1	male	0	5	11	Lung Cancer	Cancer	1	12	$25-$50k	0	7,980	4,603.7109	3,679	6	white	24.296875	21	0.555908	0.233978	1	0	metastatic	null	null	no dnr	5	68	2	106	31	36	172.5	2.099609	22.097656	3.5	136	7.349609	76	117	130	null	null	<2 mo. follow-up	2.232422
4,555	39.34598	1	male	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	null	94	37,006	24,103.6406	18,252	32	black	19.898438	33	0.662964	0.565918	3	0	no	0.02	0	dnr after sadm	4	59	9.599609	60	32	36.19531	301.625	null	null	2.5	143	7.40918	235	99	1,180	null	0	<2 mo. follow-up	0
4,556	41.90799	1	female	1	23	23	MOSF w/Malig	ARF/MOSF	1	13	$11-$25k	0	113,704	73,262.5625	57,339	28.333328	white	24	37	0.619995	0.515991	4	0	metastatic	0.2	0.1	dnr after sadm	23	127	8.898438	150	10	39.59375	218	2.899902	1.799805	0.799927	132	7.399414	107	8	630	null	4	<2 mo. follow-up	4
4,557	77.26495	1	male	1	16	16	ARF/MOSF w/Sepsis	ARF/MOSF	2	11	null	0	53,824	32,864.5625	28,672	24.333328	white	32.59375	65	0.577881	0.467957	1	1	no	0.8	0.8	dnr after sadm	16	111	6.799805	66	24	36.89844	null	null	null	3.699707	141	null	169	26	1,500	null	3	<2 mo. follow-up	3
4,558	65.67798	1	male	0	16	230	ARF/MOSF w/Sepsis	ARF/MOSF	4	2	under $11k	0	30,435	20,161.2969	19,058	16.333328	black	30.796875	59	0.618896	0.513916	1	0	yes	0.5	0.5	no dnr	16	171	11	116	26	37.69531	393.3125	null	null	1.199951	145	7.599609	144	25	1,565	4	0	no(M2 and SIP pres)	0
4,559	49.29199	1	female	0	14	221	ARF/MOSF w/Sepsis	ARF/MOSF	1	9	$25-$50k	0	23,026	14,854.1719	13,023	16.333328	white	26.699219	28	0.726929	0.642944	1	0	metastatic	0.3	0.2	no dnr	14	75	10.798828	110	24	36.5	309.5	3.399902	0.5	0.699951	134	7.459961	101	9	1,700	null	1	null	1
4,560	77.17999	1	female	1	20	20	ARF/MOSF w/Sepsis	ARF/MOSF	4	8	under $11k	9	32,283	20,509.1406	21,574	15.333328	black	32.398438	53	0.485962	0.367981	4	1	no	0.1	0.1	dnr after sadm	6	67	19.898438	124	14	38.89844	250	null	0.5	0.699951	147	7.40918	186	3	4,880	null	4	<2 mo. follow-up	4
4,561	74.52399	0	male	0	17	944	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	0	74,630	46,074.6562	46,423	19.666656	white	29.898438	55	0.564941	0.452942	14	1	no	null	null	no dnr	17	129	19.199219	136	12	39.09375	124	1.799805	0.899902	0.399963	140	7.389648	118	11	1,485	null	0	no(M2 and SIP pres)	0
4,562	76.70898	1	male	1	46	46	ARF/MOSF w/Sepsis	ARF/MOSF	2	7	under $11k	0	167,401	99,435.5	108,604	33.75	white	25	40	0.746948	0.667969	1	0	no	null	null	dnr after sadm	41	69	8.199219	100	12	36.19531	271.375	null	null	0.599976	134	7.449219	146	12	2,600	null	4	<2 mo. follow-up	4
4,563	66.59497	1	female	1	4	4	Cirrhosis	COPD/CHF/Cirrhosis	2	14	null	26	5,718	3,435.2969	3,310	16	hispanic	31.796875	66	0.338989	0.151978	1	0	no	0	0	dnr after sadm	2	41	21.199219	134	48	35.59375	72	2.299805	10.599609	0.699951	141	7.479492	85	16	1,430	null	7	<2 mo. follow-up	7
4,564	67.02795	1	male	0	6	101	COPD	COPD/CHF/Cirrhosis	2	12	$11-$25k	0	13,864	8,040.1992	8,058	22	white	17.097656	35	0.883911	0.805908	1	1	no	null	null	no dnr	6	68	10	66	22	36.59375	364	null	null	0.799927	132	7.5	87	7	1,190	0	1	no(M2 and SIP pres)	1
4,565	47.26099	1	male	0	7	266	CHF	COPD/CHF/Cirrhosis	2	6	$11-$25k	0	5,337	3,614.2812	3,325	10	black	21.796875	26	0.889893	0.815918	1	0	no	null	null	no dnr	7	63	7.599609	100	20	37.09375	null	null	0.399963	1.199951	142	null	51	6	3,200	1	2	no(M2 and SIP pres)	2
4,566	49.69199	1	male	1	6	6	Cirrhosis	COPD/CHF/Cirrhosis	1	12	$11-$25k	41	30,257	22,688.4844	17,038	32	white	37.296875	68	0.255981	0.092987	2	0	no	0.3	0.3	dnr after sadm	4	30	1.199951	0	10	37.19531	246	null	2.099609	4	137	7.289062	154	99	120	null	0	<2 mo. follow-up	0
4,567	49.5	1	female	1	15	15	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	>$50k	0	92,135	57,447.5938	53,565	53.333313	white	42.898438	69	0.397949	0.278992	6	1	no	0.6	0.6	dnr after sadm	15	67	4.5	130	28	36.79688	185.6875	3.299805	null	0.699951	143	7.459961	285	25	4,300	null	3	<2 mo. follow-up	3
4,568	72.87598	1	male	0	7	193	Lung Cancer	Cancer	3	16	null	0	6,623	4,288.4531	4,394	8.5	white	17.097656	9	0.68689	0.393982	1	0	metastatic	0.9	0.6	no dnr	7	135	16.398438	116	28	35.89844	370.3125	null	0.599976	1.299805	137	7.459961	262	29	1,458	0	0	no(M2 and SIP pres)	0
4,569	21.59299	1	male	0	20	342	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	44	35,222	22,459.4531	20,857	21.333328	white	15.599609	4	0.915894	0.884888	1	0	no	0.8	0.7	no dnr	20	63	30.597656	144	25	38.89844	74	2.399902	0.899902	0.799927	130	7.319336	111	20	2,390	null	null	Coma or Intub	1.914551
4,570	65.27295	1	male	0	11	843	ARF/MOSF w/Sepsis	ARF/MOSF	2	10	$11-$25k	0	31,903	19,699.6562	20,405	22	white	36.796875	45	0.460999	0.34198	7	0	no	0.5	0.4	no dnr	11	118	17.199219	114	34	38.69531	413.3125	3.299805	1	0.599976	136	7.479492	124	6	3,670	0	0	no(M2 and SIP pres)	0
4,571	40.30099	1	female	0	7	291	Lung Cancer	Cancer	1	16	$25-$50k	0	5,085	3,449.3496	4,165	9.5	white	33.398438	40	0.356995	0.077988	1	0	metastatic	0.8	0.5	no dnr	7	0	23.097656	0	0	39.79688	368	null	3.199707	6.099609	135	7.419922	187	67	0	0	0	no(M2 and SIP pres)	0
4,572	51.09097	0	male	0	60	940	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	under $11k	0	167,620	98,773.0625	104,292	28.25	white	33.5	71	0.618896	0.513916	12	0	no	null	null	no dnr	60	58	22.097656	95	9	35.89844	163.25	2.199707	1.799805	1.399902	128	7.399414	332	33	8,340	1	2	SIP>=30	2
4,573	31.59499	0	male	0	10	940	ARF/MOSF w/Sepsis	ARF/MOSF	1	11	null	0	27,143	16,342.8125	15,221	16.5	black	27.597656	53	0.849976	0.79895	2	0	no	null	null	no dnr	10	106	12.5	94	21	36	388.875	null	0.599976	0.899902	137	7.30957	126	22	null	1	0	no(M2 and SIP pres)	0
4,574	39.797	0	male	0	5	940	Cirrhosis	COPD/CHF/Cirrhosis	3	14	under $11k	0	5,901	3,753.3652	4,265	12	white	17	23	0.904907	0.839966	1	0	no	null	null	no dnr	5	109	28.296875	64	20	37.79688	508.6875	null	null	0.699951	130	7.479492	245	18	null	1	1	no(M2 and SIP pres)	1
4,575	58.33499	0	male	0	105	939	ARF/MOSF w/Sepsis	ARF/MOSF	1	9	$11-$25k	0	298,711	201,417.625	23,960	43.5	white	31	40	0.717896	0.631958	1	0	no	0.4	0.4	no dnr	105	55	10.398438	110	14	36.09375	170	null	null	0.5	141	7.389648	196	3	2,480	null	5	SIP>=30	5
4,576	59.34598	1	male	1	6	6	Coma	Coma	1	0	$11-$25k	94	26,989	19,152.7812	15,365	33	black	18.097656	16	0.418945	0.344971	3	0	no	0.01	0	dnr after sadm	5	138	7.599609	84	22	36.29688	null	4.099609	1	1	140	null	83	10	210	null	0	<2 mo. follow-up	0
4,577	52.94199	0	female	0	14	937	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	>$50k	0	40,230	24,462.9844	21,977	20.666656	white	17	15	0.888916	0.849976	5	0	no	0.7	0.7	no dnr	14	81	100	104	11	36.39844	159.15625	null	null	3.899902	135	7.319336	240	98	1,356	3	0	no(M2 and SIP pres)	0
4,578	44.00497	1	male	0	19	441	ARF/MOSF w/Sepsis	ARF/MOSF	0	15	$11-$25k	0	42,924	30,731.9688	28,252	28.666656	white	17.199219	11	0.914917	0.883911	2	0	no	0.8	0.8	dnr after sadm	12	62	15.699219	134	30	35.89844	122.5	2.599609	18.699219	1.799805	144	7.5	168	56	790	null	7	Coma or Intub	7
4,579	75.02295	1	male	0	8	168	Lung Cancer	Cancer	1	8	under $11k	0	9,280	5,833	5,668	10	white	15.398438	23	0.715942	0.437988	1	0	metastatic	null	null	no dnr	8	65	7.5	114	28	38.09375	208.5625	2.599609	1.599854	1.799805	146	7.359375	241	78	2,020	0	0	no(M2 and SIP pres)	0
4,580	60.52798	1	female	1	38	38	ARF/MOSF w/Sepsis	ARF/MOSF	5	12	under $11k	0	334,835	253,204	217,423	21.25	white	24.699219	49	0.67395	0.578979	73	1	yes	0.2	0.1	dnr after sadm	6	75	12	120	24	37.09375	null	1.5	0.899902	0.799927	136	null	75	21	null	null	0	<2 mo. follow-up	0
4,581	66.93799	0	male	0	38	934	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$25-$50k	0	135,947	75,008	73,737	33	white	36.09375	70	0.406982	0.287964	4	0	yes	0.4	0.3	no dnr	38	63	10.398438	104	20	37.59375	336.625	null	0.799927	1.699951	132	7.449219	245	33	880	null	2	adl>=4 (>=5 if sur)	2
4,582	69.70599	0	male	0	11	933	CHF	COPD/CHF/Cirrhosis	3	6	$25-$50k	0	23,536	15,357.625	10,738	24	white	27.597656	52	0.718994	0.562988	2	0	no	null	null	no dnr	11	119	15.199219	66	36	38.19531	303.3125	null	null	0.899902	133	7.509766	200	7	2,280	1	7	no(M2 and SIP pres)	7
4,583	70.43896	1	male	0	15	613	ARF/MOSF w/Sepsis	ARF/MOSF	3	4	null	9	38,926	25,641.9844	21,850	24.333328	white	26.199219	73	0.7229	0.637939	1	0	no	0.6	0.5	no dnr	15	79	0.699951	114	45	36.19531	316.625	null	3.5	8.099609	153	7.459961	186	144	3,480	null	null	no(M2 and SIP pres)	2.557617
4,584	92.15594	1	male	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	1	5	null	0	11,834	6,943.1367	6,614	31	white	57.5	95	0.003	0	2	1	no	null	null	dnr after sadm	1	63	12	120	12	36.09375	263.3125	2	2.799805	0.699951	141	7.459961	140	19	2,365	null	0	<2 mo. follow-up	0
4,585	45.59598	0	female	0	14	933	ARF/MOSF w/Sepsis	ARF/MOSF	1	11	$11-$25k	0	31,083	20,342.7344	18,127	8.666664	black	17.699219	32	0.903931	0.869995	3	0	no	0.85	0.8	no dnr	14	96	7.299805	70	20	36.29688	null	4.099609	1	1.5	136	null	139	31	null	5	0	null	0
4,586	21.85899	1	male	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	159,990	98,132.5	61,458	69	white	38.796875	72	0.635986	0.533936	48	0	no	null	null	dnr after sadm	4	65	14.099609	106	20	35.69531	null	3.899902	null	0.899902	128	null	97	14	null	null	null	<2 mo. follow-up	2.019531
4,587	49.69199	1	female	1	110	110	ARF/MOSF w/Sepsis	ARF/MOSF	3	9	under $11k	0	536,290	null	null	34.25	black	36.296875	66	0.590942	0.481995	5	1	no	0.3	0.2	dnr after sadm	69	78	19.097656	64	9	36.59375	380	2.299805	1.599854	5	129	7.379883	230	99	1,290	null	1	adl>=4 (>=5 if sur)	1
4,588	70.83099	1	male	0	25	270	ARF/MOSF w/Sepsis	ARF/MOSF	3	4	under $11k	0	39,684	25,477.6406	31,305	12.5	other	24.398438	33	0.779907	0.708984	1	1	no	0.8	0.75	no dnr	25	61	17.699219	106	40	38.59375	177.5	2.099609	0.899902	3.299805	151	7.469727	190	149	173	null	6	adl>=4 (>=5 if sur)	6
4,589	62.54599	1	male	0	13	189	MOSF w/Malig	ARF/MOSF	4	14	$25-$50k	0	40,684	25,259.9219	27,094	32.5	white	31.5	47	0.520996	0.404968	1	0	yes	0.7	0.5	no dnr	13	73	8.398438	70	28	36.19531	191.40625	null	null	0.5	139	7.389648	80	16	1,100	1	6	adl>=4 (>=5 if sur)	6
4,590	79.95294	1	male	1	26	26	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	under $11k	41	101,923	70,486.75	59,330	34.5	black	17.5	36	0.736938	0.655884	1	0	no	0.6	0.5	dnr after sadm	23	119	37.296875	176	28	36	223.3125	2.299805	0.299988	0.699951	142	7.5	148	47	1,910	null	null	<2 mo. follow-up	2.765137
4,591	60.20499	1	male	0	12	193	ARF/MOSF w/Sepsis	ARF/MOSF	1	7	under $11k	0	36,077	22,552.1875	21,125	34	white	27.699219	55	0.768921	0.694946	1	1	no	0.4	0.25	no dnr	12	113	28.097656	106	44	39	240	null	4.5	0.699951	137	7.419922	117	8	4,900	null	1	no(M2 and SIP pres)	1
4,592	58.09998	1	male	0	13	108	Lung Cancer	Cancer	2	null	null	0	12,119	7,854.8711	7,984	7.5	white	14.199219	13	0.773926	0.529907	1	0	metastatic	0.8	0.4	no dnr	13	27	15.599609	135	12	37.89844	218	1.799805	null	2.399902	135	7.289062	43	48	140	null	null	null	2.822266
4,593	82.37396	1	female	0	20	826	ARF/MOSF w/Sepsis	ARF/MOSF	2	7	$11-$25k	0	52,865	36,617.4062	33,561	25.666656	black	30	44	0.573975	0.463989	3	1	no	0.5	0.4	no dnr	20	53	17	70	34	38.79688	122	null	0.699951	1.599854	151	7.479492	185	28	2,080	null	0	no(M2 and SIP pres)	0
4,594	70.18799	0	female	0	15	926	ARF/MOSF w/Sepsis	ARF/MOSF	0	8	null	9	46,529	31,239.9219	25,634	27	black	17.597656	23	0.851929	0.80188	1	0	no	0.25	0.2	no dnr	15	76	4	120	28	38.09375	null	2.199707	0.599976	1.899902	131	null	103	48	1,150	null	0	no(M2 and SIP pres)	0
4,595	66.44995	1	female	0	19	69	Coma	Coma	3	null	null	55	28,300	19,586.7188	21,057	13.666664	black	24.199219	52	0.415955	0.342957	1	1	no	0.8	0.7	dnr after sadm	1	145	26	144	35	39	84.60938	null	0.399963	0.899902	139	7.439453	94	19	2,595	null	7	null	7
4,596	72.43298	0	female	0	42	926	ARF/MOSF w/Sepsis	ARF/MOSF	0	8	under $11k	0	48,857	32,073.5781	38,315	14.25	white	22.199219	28	0.807983	0.743896	1	0	no	0.7	0.5	no dnr	42	71	7	64	22	36.59375	291.25	null	null	1.199951	141	7.399414	197	20	1,220	0	null	no(M2 and SIP pres)	0.494751
4,597	40.70398	1	male	0	71	99	CHF	COPD/CHF/Cirrhosis	3	12	under $11k	0	207,743	131,070.938	31,629	25.75	black	32	32	0.793945	0.668945	1	0	no	null	null	dnr after sadm	39	79	7.599609	116	24	37.79688	null	null	0.399963	1	141	null	103	14	1,925	2	6	adl>=4 (>=5 if sur)	6
4,598	83.76495	1	male	0	4	99	CHF	COPD/CHF/Cirrhosis	3	9	$11-$25k	0	5,175	3,558.0781	2,754	17	white	18.796875	29	0.814941	0.699951	1	1	no	0.5	0.25	no dnr	4	124	12.298828	136	26	38.39844	142	4.599609	0.199982	1.299805	144	7.419922	474	20	2,155	3	3	adl>=4 (>=5 if sur)	3
4,599	37.80399	1	male	0	5	182	Lung Cancer	Cancer	1	null	null	0	5,296	3,480.457	3,060	2	white	10.5	14	0.85498	0.677979	1	0	metastatic	0.9	0.5	no dnr	5	122	9.599609	140	28	36.89844	null	null	null	1	140	null	148	5	null	null	null	null	1.781982
4,600	73.57996	1	male	1	7	7	MOSF w/Malig	ARF/MOSF	2	14	$11-$25k	0	51,620	33,419.8125	31,452	29.5	white	33.09375	60	0.343994	0.227997	12	1	yes	0.9	0.8	dnr after sadm	7	0	1.199951	0	0	38.89844	93.32812	null	1.799805	3.799805	136	7.259766	91	88	1,510	null	null	<2 mo. follow-up	2.959473

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.